首页 > 最新文献

Laeknabladid最新文献

英文 中文
[Gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet]. [肠易激综合征患者采用低 FODMAP 饮食后的胃肠道症状和饮食摄入量]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2024-06-01 DOI: 10.17992/lbl.2024.05.796
Ingunn Erla Ingvarsdottir, Svava Engilbertsdottir, Thorhallur Ingi Halldorsson, Einar Stefan Bjornsson, Ingibjorg Gunnarsdottir

Introduction: High FODMAP (fermentable oligo-, di, monosaccharides and polyols) foods have been linked with worsening symptoms of IBS patients. The aim was to compare gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet, with or without individual nutrition therapy.

Materials and methods: A total of 54 patients that met Rome IV criteria for IBS were randomized into two groups, guided group (individual nutrition therapy, n=28) and self-management group (learned about low FODMAP diet online, n=26). Both groups followed low FODMAP diet for 4 weeks. Four-day food records were used to assess dietary intake. Symptoms were assessed by the IBS-severity scoring system (ISB-SSS).

Results: The number of subjects who did not complete the study was 13, thereof five in the nutrition therapy and eight in the self-management group, leaving 23 and 18 subjects available for analysis, respectively. Symptoms declined from baseline to endpoint in both groups, by 183±101 points on average in the group receiving nutrition therapy (p< 0.001) and 132±110 points in the self-management group (p< 0.001), with no difference between groups. At baseline, about 80% of meals in both groups contained food high in FODMAP's. The corresponding proportion was 9% and 36% in week 3 in the nutrition therapy and self-management group, respectively (p< 0.001).

Conclusion: Both groups experienced relieve of symptoms, but compliance to the low FODMAP diet was better in the group receiving individual nutrition therapy compared with the group who only received instructions on how to learn about low FODMAP diet online.

导言:高 FODMAP(可发酵低聚糖、双糖、单糖和多元醇)食物与肠易激综合征患者症状的恶化有关。本研究旨在比较肠易激综合征患者在接受或不接受个体营养治疗的情况下摄入低 FODMAP 饮食后的胃肠道症状和饮食摄入量:54名符合罗马IV标准的肠易激综合征患者被随机分为两组,指导组(个体营养治疗,28人)和自我管理组(在线了解低FODMAP饮食,26人)。两组均遵循低 FODMAP 饮食 4 周。采用四天食物记录来评估饮食摄入量。通过肠易激综合征严重程度评分系统(ISB-SSS)对症状进行评估:未完成研究的受试者人数为 13 人,其中营养治疗组 5 人,自我管理组 8 人,可供分析的受试者人数分别为 23 人和 18 人。从基线到终点,两组受试者的症状均有所减轻,营养治疗组平均减轻了183±101分(P< 0.001),自我管理组平均减轻了132±110分(P< 0.001),组间无差异。基线时,两组中约有 80% 的膳食含有高 FODMAP 食物。营养治疗组和自我管理组在第3周的相应比例分别为9%和36%(P< 0.001):结论:两组患者的症状均有所缓解,但接受个体营养治疗组患者对低 FODMAP 饮食的依从性优于仅接受如何在线了解低 FODMAP 饮食指导的组患者。
{"title":"[Gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet].","authors":"Ingunn Erla Ingvarsdottir, Svava Engilbertsdottir, Thorhallur Ingi Halldorsson, Einar Stefan Bjornsson, Ingibjorg Gunnarsdottir","doi":"10.17992/lbl.2024.05.796","DOIUrl":"10.17992/lbl.2024.05.796","url":null,"abstract":"<p><strong>Introduction: </strong>High FODMAP (fermentable oligo-, di, monosaccharides and polyols) foods have been linked with worsening symptoms of IBS patients. The aim was to compare gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet, with or without individual nutrition therapy.</p><p><strong>Materials and methods: </strong>A total of 54 patients that met Rome IV criteria for IBS were randomized into two groups, guided group (individual nutrition therapy, n=28) and self-management group (learned about low FODMAP diet online, n=26). Both groups followed low FODMAP diet for 4 weeks. Four-day food records were used to assess dietary intake. Symptoms were assessed by the IBS-severity scoring system (ISB-SSS).</p><p><strong>Results: </strong>The number of subjects who did not complete the study was 13, thereof five in the nutrition therapy and eight in the self-management group, leaving 23 and 18 subjects available for analysis, respectively. Symptoms declined from baseline to endpoint in both groups, by 183±101 points on average in the group receiving nutrition therapy (p< 0.001) and 132±110 points in the self-management group (p< 0.001), with no difference between groups. At baseline, about 80% of meals in both groups contained food high in FODMAP's. The corresponding proportion was 9% and 36% in week 3 in the nutrition therapy and self-management group, respectively (p< 0.001).</p><p><strong>Conclusion: </strong>Both groups experienced relieve of symptoms, but compliance to the low FODMAP diet was better in the group receiving individual nutrition therapy compared with the group who only received instructions on how to learn about low FODMAP diet online.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141162851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cancer registration in Iceland for 70 years - incidence, mortality and survival]. [冰岛 70 年来癌症登记情况--发病率、死亡率和存活率]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2024-06-01 DOI: 10.17992/lbl.2024.06.797
Alfheidur Haraldsdottir, Helgi Birgisson, Elinborg Jona Olafsdottir, Sigridur Gunnarsdottir, Laufey Tryggvadottir

Introduction: The Icelandic Cancer Registry (ICR) was founded seventy years ago by the Icelandic Cancer Society. In 2007 the ICR became one of the health registers of the Directorate of Health. In this paper we present cancer incidence, mortality, and survival in Iceland over 70 years.

Material and methods: The ICR receives information on cancer diagnoses from histopathological laboratories, the Hospital Discharge Registry and the Cause of Death Registry. Iceland participates in the Nordic cancer database NORDCAN. Because of the small population size, random variation in numbers is very prominent. Therefore, data from ICR are published as five-year averages.

Results: For all malignancies combined, age-standardized incidence (ASI) in men rose steadily until around 15 years ago when a decline started. This is in line with prostate- and lung cancer incidence trends. In women, the ASI was lower than in men, but it is still on the rise despite declining lung cancer incidence. ASI for breast cancer, the most common cancer in women, is increasing. Simultaneously, cancer mortality for both sexes has declined in recent years and cancer survival is improving.

Conclusions: Population-based cancer registration for over 70 years makes it possible to monitor the epidemiology of cancer in Iceland and compare with other countries. The changes in trends in ASI are in line with changes of cancer risk factors and diagnostic policy. The decline in cancer mortality and improvement in survival reflects advances in cancer treatment as well as effects of early detection and prevention.

导言:冰岛癌症登记处(ICR)由冰岛癌症协会于七十年前成立。2007 年,ICR 成为卫生局的健康登记册之一。本文介绍了 70 年来冰岛的癌症发病率、死亡率和存活率:国际癌症登记处从组织病理学实验室、出院登记处和死因登记处获得癌症诊断信息。冰岛加入了北欧癌症数据库 NORDCAN。由于人口规模小,数字的随机变化非常明显。因此,ICR 的数据以五年平均值发布:在所有恶性肿瘤中,男性的年龄标准化发病率(ASI)一直在稳步上升,直到大约 15 年前才开始下降。这与前列腺癌和肺癌的发病趋势一致。女性的年龄标准化发病率低于男性,但尽管肺癌发病率下降,女性的年龄标准化发病率仍呈上升趋势。女性最常见的癌症--乳腺癌的 ASI 正在上升。同时,近年来男女癌症死亡率均有所下降,癌症生存率也在提高:结论:70 多年来基于人口的癌症登记使我们有可能对冰岛的癌症流行病学进行监测,并与其他国家进行比较。ASI趋势的变化与癌症风险因素和诊断政策的变化是一致的。癌症死亡率的下降和生存率的提高反映了癌症治疗的进步以及早期检测和预防的效果。
{"title":"[Cancer registration in Iceland for 70 years - incidence, mortality and survival].","authors":"Alfheidur Haraldsdottir, Helgi Birgisson, Elinborg Jona Olafsdottir, Sigridur Gunnarsdottir, Laufey Tryggvadottir","doi":"10.17992/lbl.2024.06.797","DOIUrl":"10.17992/lbl.2024.06.797","url":null,"abstract":"<p><strong>Introduction: </strong>The Icelandic Cancer Registry (ICR) was founded seventy years ago by the Icelandic Cancer Society. In 2007 the ICR became one of the health registers of the Directorate of Health. In this paper we present cancer incidence, mortality, and survival in Iceland over 70 years.</p><p><strong>Material and methods: </strong>The ICR receives information on cancer diagnoses from histopathological laboratories, the Hospital Discharge Registry and the Cause of Death Registry. Iceland participates in the Nordic cancer database NORDCAN. Because of the small population size, random variation in numbers is very prominent. Therefore, data from ICR are published as five-year averages.</p><p><strong>Results: </strong>For all malignancies combined, age-standardized incidence (ASI) in men rose steadily until around 15 years ago when a decline started. This is in line with prostate- and lung cancer incidence trends. In women, the ASI was lower than in men, but it is still on the rise despite declining lung cancer incidence. ASI for breast cancer, the most common cancer in women, is increasing. Simultaneously, cancer mortality for both sexes has declined in recent years and cancer survival is improving.</p><p><strong>Conclusions: </strong>Population-based cancer registration for over 70 years makes it possible to monitor the epidemiology of cancer in Iceland and compare with other countries. The changes in trends in ASI are in line with changes of cancer risk factors and diagnostic policy. The decline in cancer mortality and improvement in survival reflects advances in cancer treatment as well as effects of early detection and prevention.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141162845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Perioperative stroke after aortic valve replacement for aortic stenosis - incidence, risk factors and short-term outcome]. [主动脉瓣狭窄主动脉瓣置换术后围手术期中风--发生率、风险因素和短期疗效]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2024-05-01 DOI: 10.17992/lbl.2024.05.792
Elin Metta Jensen, Katrin Juniana Larusdottir, Erla Liu Ting Gunnarsdottir, Sunna Lu Xi Gunnarsdottir, Anders Jeppsson, Tomas Gudbjartsson

Introduction: One of the most serious complications of surgical aortic valve replacement (SAVR) is stroke that can result in increased rates of complications, morbidity and mortality postoperatively. The aim of this study was to investigate incidence, risk factors and short-term outcome in a well defined cohort of SAVR-patients.

Materials and method: A retrospective study on 740 consecutive aortic stenosis patients who underwent SAVR in Iceland 2002-2019. Patients with stroke were compared with non-stroke patients; including preoperative risk factors of cardiovascular disease, echocardiogram-results, rate of early postoperative complications other than stroke and 30 day mortality.

Results: Mean age was 71 yrs (34% females) with 57% of the patients receiving stented bioprosthesis, 31% a stentless Freestyle®-valve and 12% a mechanical valve. Mean EuroSCORE-II was 3.6, with a maximum preop-gradient of 70 mmHg and an estimated valvular area of 0.73 cm2. Thirteen (1.8%) patients were diagnosed with stroke where hemiplegia (n=9), loss of consciousness (n=3) and/or aphasia (n=4) were the most common presenting symptoms. In 70% of cases the neurological symptoms resolved or disappeared in the first weeks and months after surgery. Only one patient out of 13 died within 30-days (7.7%). Stroke-patients had significantly lower BMI than non-stroke patients, but other risk factors of cardiovascular diseases, intraoperative factors or the rate of other severe postoperative complications than stroke were similar between groups. Total length of stay was 14 days vs. 10 days median, including 2 vs. 1 days in the ICU, in the stroke and non-stroke-groups, respectively.

Conclusions: The rate of stroke after SAVR was low (1.8%) and in line with other similar studies. Although a severe complication, most patients with perioperative stroke survived 30 days postoperatively and in majority of cases neurological symptoms recovered.

导言:手术主动脉瓣置换术(SAVR)最严重的并发症之一是中风,可导致术后并发症、发病率和死亡率增加。本研究旨在调查一组明确定义的 SAVR 患者的发病率、风险因素和短期疗效:对 2002-2019 年在冰岛接受 SAVR 的 740 名连续主动脉瓣狭窄患者进行回顾性研究。将中风患者与非中风患者进行比较,包括术前心血管疾病风险因素、超声心动图结果、除中风外的术后早期并发症发生率和 30 天死亡率:平均年龄为71岁(34%为女性),57%的患者接受了支架生物瓣膜,31%接受了无支架Freestyle®瓣膜,12%接受了机械瓣膜。EuroSCORE-II平均值为3.6,术前最大坡度为70毫米汞柱,估计瓣膜面积为0.73平方厘米。13例(1.8%)患者被诊断为中风,偏瘫(9例)、意识丧失(3例)和/或失语(4例)是最常见的症状。在 70% 的病例中,神经症状在术后数周或数月内缓解或消失。13名患者中只有一名在30天内死亡(7.7%)。中风患者的体重指数(BMI)明显低于非中风患者,但两组患者的其他心血管疾病风险因素、术中因素或除中风以外的其他严重术后并发症发生率相似。中风组和非中风组的总住院时间中位数分别为14天和10天,其中重症监护室住院时间分别为2天和1天:结论:SAVR术后中风发生率较低(1.8%),与其他类似研究结果一致。结论:SAVR术后脑卒中发生率较低(1.8%),与其他类似研究结果一致。虽然脑卒中是一种严重并发症,但大多数围手术期脑卒中患者都能在术后30天内存活,而且大部分患者的神经症状都已恢复。
{"title":"[Perioperative stroke after aortic valve replacement for aortic stenosis - incidence, risk factors and short-term outcome].","authors":"Elin Metta Jensen, Katrin Juniana Larusdottir, Erla Liu Ting Gunnarsdottir, Sunna Lu Xi Gunnarsdottir, Anders Jeppsson, Tomas Gudbjartsson","doi":"10.17992/lbl.2024.05.792","DOIUrl":"https://doi.org/10.17992/lbl.2024.05.792","url":null,"abstract":"<p><strong>Introduction: </strong>One of the most serious complications of surgical aortic valve replacement (SAVR) is stroke that can result in increased rates of complications, morbidity and mortality postoperatively. The aim of this study was to investigate incidence, risk factors and short-term outcome in a well defined cohort of SAVR-patients.</p><p><strong>Materials and method: </strong>A retrospective study on 740 consecutive aortic stenosis patients who underwent SAVR in Iceland 2002-2019. Patients with stroke were compared with non-stroke patients; including preoperative risk factors of cardiovascular disease, echocardiogram-results, rate of early postoperative complications other than stroke and 30 day mortality.</p><p><strong>Results: </strong>Mean age was 71 yrs (34% females) with 57% of the patients receiving stented bioprosthesis, 31% a stentless Freestyle®-valve and 12% a mechanical valve. Mean EuroSCORE-II was 3.6, with a maximum preop-gradient of 70 mmHg and an estimated valvular area of 0.73 cm2. Thirteen (1.8%) patients were diagnosed with stroke where hemiplegia (n=9), loss of consciousness (n=3) and/or aphasia (n=4) were the most common presenting symptoms. In 70% of cases the neurological symptoms resolved or disappeared in the first weeks and months after surgery. Only one patient out of 13 died within 30-days (7.7%). Stroke-patients had significantly lower BMI than non-stroke patients, but other risk factors of cardiovascular diseases, intraoperative factors or the rate of other severe postoperative complications than stroke were similar between groups. Total length of stay was 14 days vs. 10 days median, including 2 vs. 1 days in the ICU, in the stroke and non-stroke-groups, respectively.</p><p><strong>Conclusions: </strong>The rate of stroke after SAVR was low (1.8%) and in line with other similar studies. Although a severe complication, most patients with perioperative stroke survived 30 days postoperatively and in majority of cases neurological symptoms recovered.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140877762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Allocation and diversity of grants]. [补助金的分配和多样性]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2024-05-01 DOI: 10.17992/lbl.2024.05.790
Katrin Thorarinsdottir
{"title":"[Allocation and diversity of grants].","authors":"Katrin Thorarinsdottir","doi":"10.17992/lbl.2024.05.790","DOIUrl":"https://doi.org/10.17992/lbl.2024.05.790","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140877760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Psychedelics in treatment of postraumatic stress disorder]. [治疗创伤后应激障碍的迷幻剂]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2024-05-01 DOI: 10.17992/lbl.2024.05.791
Magnus Haraldsson
{"title":"[Psychedelics in treatment of postraumatic stress disorder].","authors":"Magnus Haraldsson","doi":"10.17992/lbl.2024.05.791","DOIUrl":"https://doi.org/10.17992/lbl.2024.05.791","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140877763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[MDMA-assisted therapy for PTSD]. [MDMA辅助治疗创伤后应激障碍]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2024-05-01 DOI: 10.17992/lbl.2024.05.793
Helga Thorarinsdottir, Berglind Gudmundsdottir, Engilbert Sigurdsson

MDMA is a potential novel treatment for post-traumatic stress disorder (PTSD). Our goal is to review current knowledge on MDMA and its use in MDMA-assisted psychotherapy for PTSD. Literature searches were done on PubMed, Web of Science and Google Scholar and references reviewed in identified articles. MDMA-assisted therapy for PTSD usually consists of a few preparatory sessions before two or three sessions where one or two oral doses of MDMA are given along with supportive psychotherapy. The therapy is delivered in the presence of two therapists for about eight hours each time. In addition, the patient receives up to 9 integrative sessions in due course. This use of MDMA as a part of psychotherapy for PTSD is proposed to lessen the psychological distress that often arises in the processing of traumatic events to facilitate the treatment process and reduce the risk of drop-out. Recent studies indicate that MDMA-assisted psychotherapy reduces PTSD symptoms and is generally well tolerated. These studies are necessary if this MDMA-assisted treatment is to be approved by licensing authorities. There is an urgent need for new effective treatments for PTSD and for comparisons between this MDMA-assisted psychotherapy and currently approved psychotherapies with and without MDMA-use.

摇头丸是一种治疗创伤后应激障碍(PTSD)的潜在新型疗法。我们的目标是回顾当前有关摇头丸的知识以及摇头丸辅助心理疗法在创伤后应激障碍中的应用。我们在 PubMed、Web of Science 和 Google Scholar 上进行了文献检索,并查阅了已确定文章的参考文献。针对创伤后应激障碍的亚甲二氧基甲基苯丙胺辅助疗法通常包括几个预备疗程,然后再进行两到三个疗程的治疗,在这些疗程中口服一到两次亚甲二氧基甲基苯丙胺,同时进行支持性心理治疗。每次治疗都有两名治疗师在场,时间约为八小时。此外,患者还会适时接受多达 9 次综合治疗。建议将亚甲二氧基甲基苯丙胺作为创伤后应激障碍心理治疗的一部分,以减轻患者在处理创伤事件过程中经常出现的心理困扰,从而促进治疗过程并降低辍学风险。最近的研究表明,MDMA 辅助心理疗法可减轻创伤后应激障碍症状,而且一般都能很好地耐受。如果这种亚甲二氧基甲基苯丙胺辅助疗法要获得许可机构的批准,就必须进行这些研究。目前迫切需要对创伤后应激障碍进行新的有效治疗,并对这种亚甲二氧基甲基苯丙胺辅助心理疗法与目前批准的使用或不使用亚甲二氧基甲基苯丙胺的心理疗法进行比较。
{"title":"[MDMA-assisted therapy for PTSD].","authors":"Helga Thorarinsdottir, Berglind Gudmundsdottir, Engilbert Sigurdsson","doi":"10.17992/lbl.2024.05.793","DOIUrl":"10.17992/lbl.2024.05.793","url":null,"abstract":"<p><p>MDMA is a potential novel treatment for post-traumatic stress disorder (PTSD). Our goal is to review current knowledge on MDMA and its use in MDMA-assisted psychotherapy for PTSD. Literature searches were done on PubMed, Web of Science and Google Scholar and references reviewed in identified articles. MDMA-assisted therapy for PTSD usually consists of a few preparatory sessions before two or three sessions where one or two oral doses of MDMA are given along with supportive psychotherapy. The therapy is delivered in the presence of two therapists for about eight hours each time. In addition, the patient receives up to 9 integrative sessions in due course. This use of MDMA as a part of psychotherapy for PTSD is proposed to lessen the psychological distress that often arises in the processing of traumatic events to facilitate the treatment process and reduce the risk of drop-out. Recent studies indicate that MDMA-assisted psychotherapy reduces PTSD symptoms and is generally well tolerated. These studies are necessary if this MDMA-assisted treatment is to be approved by licensing authorities. There is an urgent need for new effective treatments for PTSD and for comparisons between this MDMA-assisted psychotherapy and currently approved psychotherapies with and without MDMA-use.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140877761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Gastroschisis and omphalocele: Incidence and outcome]. [胃畸形和脐膨出:发病率和结果]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2024-03-01 DOI: 10.17992/lbl.2024.03.785
Kristin Fjola Reynisdottir, Hulda Hjartardottir, Thrainn Rosmundsson, Thordur Thorkelsson

Introduction: Gastroschisis and omphalocele are the most common congenital abdominal wall defects. The main purpose of this study was to investigate the incidence, other associated anomalies and the course of these diseases in Iceland.

Material and methods: The study was retrospective. The population was all newborns who were admitted to the NICU of Children's Hospital Iceland due to gastroschisis or omphalocele in 1991-2020. Furthermore, all fetuses diagnosed prenatally or post mortem where the pregnancy ended in spontaneous or induced abortion, were included.

Results: During the study period, 54 infants were born with gastroschisis and five with omphalocele. The incidence of gastroschisis was 4.11 and omphalocele 0,38/10,000 births. There was no significant change in the incidence of the diseases during the study period. In addition, five fetuses were diagnosed with gastroschisis and 31 with omphalocele where the pregnancy was terminated. In addition to gastroschisis in the live born infants and fetuses the most common associated anomalies were in the gastrointestinal or urinary tract but in infants and fetuses with omphalocele anomalies of the cardiac, central nervous or skeletal systems were the most common. Sixteen fetuses diagnosed with omphalocele had trisomy 18. Mothers aged 16-20 were more likely to give birth to an infant with gastroschisis than older mothers (p< 0.001). Primary closure was successful in 86% of the infants. Those reached full feedings significantly earlier and were discharged earlier. Overall survival rate was 95%. Three children were still receiving parenteral nutrition at discharge due to short bowel syndrome.

Conclusions: The incidence of gastroschisis in Iceland is in accordance with studies in other countries but but the incidence of omphalocele is lower, which can be partly explained by spontaneous or induced abortions. Other anomalies associated with omphalocele are more severe than those associated with gastroschisis. Primary closure was associated with more benign course. Children with gastroschisis may need prolonged parenteral nutrition due to shortening of their intestines.

导言胃裂和脐裂是最常见的先天性腹壁缺损。本研究的主要目的是调查这些疾病在冰岛的发病率、其他相关畸形和病程:本研究为回顾性研究。研究对象为 1991-2020 年间因胃螺裂或卵圆孔畸形入住冰岛儿童医院新生儿重症监护室的所有新生儿。此外,所有经产前或死后诊断为自然流产或人工流产的胎儿也包括在内:研究期间,54 名婴儿患有胃裂,5 名婴儿患有脐膨出。胃裂发生率为 4.11,脐膨出发生率为 0.38/10,000。在研究期间,这些疾病的发病率没有明显变化。此外,有 5 名胎儿被诊断出患有胃裂,31 名胎儿被诊断出患有脐膨出而终止妊娠。在活产婴儿和胎儿中,除了胃畸形外,最常见的相关畸形是胃肠道或泌尿道畸形,但在患有脐膨出的婴儿和胎儿中,最常见的是心脏、中枢神经或骨骼系统畸形。16 名确诊为脐膨出的胎儿患有 18 三体综合征。与年龄较大的母亲相比,16-20 岁的母亲更有可能生下患有胃裂的婴儿(P< 0.001)。86%的婴儿一次闭合成功。这些婴儿能更早地吃饱,也更早出院。总体存活率为 95%。3名患儿因短肠综合征在出院时仍在接受肠外营养:冰岛的胃畸形发病率与其他国家的研究结果一致,但脐膨出的发病率较低,部分原因可能是自然流产或人工流产。与脐膨出相关的其他畸形比与胃裂相关的畸形更为严重。原发性闭合与良性病程有关。患有胃裂的儿童可能因肠道缩短而需要长期肠外营养。
{"title":"[Gastroschisis and omphalocele: Incidence and outcome].","authors":"Kristin Fjola Reynisdottir, Hulda Hjartardottir, Thrainn Rosmundsson, Thordur Thorkelsson","doi":"10.17992/lbl.2024.03.785","DOIUrl":"10.17992/lbl.2024.03.785","url":null,"abstract":"<p><strong>Introduction: </strong>Gastroschisis and omphalocele are the most common congenital abdominal wall defects. The main purpose of this study was to investigate the incidence, other associated anomalies and the course of these diseases in Iceland.</p><p><strong>Material and methods: </strong>The study was retrospective. The population was all newborns who were admitted to the NICU of Children's Hospital Iceland due to gastroschisis or omphalocele in 1991-2020. Furthermore, all fetuses diagnosed prenatally or post mortem where the pregnancy ended in spontaneous or induced abortion, were included.</p><p><strong>Results: </strong>During the study period, 54 infants were born with gastroschisis and five with omphalocele. The incidence of gastroschisis was 4.11 and omphalocele 0,38/10,000 births. There was no significant change in the incidence of the diseases during the study period. In addition, five fetuses were diagnosed with gastroschisis and 31 with omphalocele where the pregnancy was terminated. In addition to gastroschisis in the live born infants and fetuses the most common associated anomalies were in the gastrointestinal or urinary tract but in infants and fetuses with omphalocele anomalies of the cardiac, central nervous or skeletal systems were the most common. Sixteen fetuses diagnosed with omphalocele had trisomy 18. Mothers aged 16-20 were more likely to give birth to an infant with gastroschisis than older mothers (p< 0.001). Primary closure was successful in 86% of the infants. Those reached full feedings significantly earlier and were discharged earlier. Overall survival rate was 95%. Three children were still receiving parenteral nutrition at discharge due to short bowel syndrome.</p><p><strong>Conclusions: </strong>The incidence of gastroschisis in Iceland is in accordance with studies in other countries but but the incidence of omphalocele is lower, which can be partly explained by spontaneous or induced abortions. Other anomalies associated with omphalocele are more severe than those associated with gastroschisis. Primary closure was associated with more benign course. Children with gastroschisis may need prolonged parenteral nutrition due to shortening of their intestines.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Perinatal outcomes of preterm births occuring to native-born and migrant mothers in Iceland]. [冰岛本地出生母亲和移民母亲早产的围产期结果]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2024-03-01 DOI: 10.17992/lbl.2024.03.784
Asdis Bjork Gunnarsdottir, Thordur Thorkelsson, Ragnheidur I Bjarnadottir, Embla Yr Gudmundsdottir

Introduction: The aim of this study was to assess the incidence and perinatal outcomes of preterm births in Iceland during 1997-2018 and compare outcomes of Icelandic and migrant mothers.

Methods: The population in this historical population-based cohort study was all preterm (p<37 weeks gestation) live-born singletons born in Iceland from January 1, 1997 to December 31, 2018 and their mothers; a total of 3837 births. Data was obtained from the Icelandic Medical Birth Registry. The group of migrant women was defined as women with other citizenship than Icelandic. Migrant women were divided into three groups based on their country of citizenship Human Development Index (HDI). Both descriptive and analytical statistics were used in data processing.

Results: The incidence of preterm births in Iceland increased during the study period (3,9% 1998-2001 vs. 4,5% 2012-2018, p<005) and was significantly higher among migrant mothers, especially from countries with the lowest HDI (OR 1,49 (CI 1,21-1,81) p<,001). Infants of mothers from countries with the lowest HDI had a significantly lower prevalence of respiratory distress syndrome compared with infants of Icelandic mothers (4,5% vs. 11,4%, p=0,035) meanwhile infants of mothers from countries with a medium high HDI were more often small for gestational age compared with infants of Icelandic mothers (11,4% vs. 6,9%, p=0,021).

Conclusion: Preterm births have become more common in Iceland and the incidence is significantly higher among migrant mothers, however the outcomes of preterm infants are generally good and mostly comparable between Icelandic and migrant mothers.

导言:本研究旨在评估1997-2018年间冰岛早产儿的发病率和围产期结局,并比较冰岛母亲和移民母亲的结局:这项基于人口的历史性队列研究的对象是所有早产儿(pResults:在研究期间,冰岛的早产发生率有所上升(1998-2001年为3.9%,2012-2018年为4.5%,p结论:早产在冰岛已变得越来越普遍,而移民母亲的早产发生率明显更高,但早产儿的预后普遍良好,冰岛母亲和移民母亲的预后基本相当。
{"title":"[Perinatal outcomes of preterm births occuring to native-born and migrant mothers in Iceland].","authors":"Asdis Bjork Gunnarsdottir, Thordur Thorkelsson, Ragnheidur I Bjarnadottir, Embla Yr Gudmundsdottir","doi":"10.17992/lbl.2024.03.784","DOIUrl":"10.17992/lbl.2024.03.784","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this study was to assess the incidence and perinatal outcomes of preterm births in Iceland during 1997-2018 and compare outcomes of Icelandic and migrant mothers.</p><p><strong>Methods: </strong>The population in this historical population-based cohort study was all preterm (p<37 weeks gestation) live-born singletons born in Iceland from January 1, 1997 to December 31, 2018 and their mothers; a total of 3837 births. Data was obtained from the Icelandic Medical Birth Registry. The group of migrant women was defined as women with other citizenship than Icelandic. Migrant women were divided into three groups based on their country of citizenship Human Development Index (HDI). Both descriptive and analytical statistics were used in data processing.</p><p><strong>Results: </strong>The incidence of preterm births in Iceland increased during the study period (3,9% 1998-2001 vs. 4,5% 2012-2018, p<005) and was significantly higher among migrant mothers, especially from countries with the lowest HDI (OR 1,49 (CI 1,21-1,81) p<,001). Infants of mothers from countries with the lowest HDI had a significantly lower prevalence of respiratory distress syndrome compared with infants of Icelandic mothers (4,5% vs. 11,4%, p=0,035) meanwhile infants of mothers from countries with a medium high HDI were more often small for gestational age compared with infants of Icelandic mothers (11,4% vs. 6,9%, p=0,021).</p><p><strong>Conclusion: </strong>Preterm births have become more common in Iceland and the incidence is significantly higher among migrant mothers, however the outcomes of preterm infants are generally good and mostly comparable between Icelandic and migrant mothers.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[General Practicioners Activist Group]. [全科医生活动小组]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2024-03-01 DOI: 10.17992/lbl.2024.03.782
Gunnar Thor Geirsson
{"title":"[General Practicioners Activist Group].","authors":"Gunnar Thor Geirsson","doi":"10.17992/lbl.2024.03.782","DOIUrl":"10.17992/lbl.2024.03.782","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Rare diseases in Iceland]. [冰岛的罕见疾病]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2024-03-01 DOI: 10.17992/lbl.2024.03.783
Olof Jona Eliasdottir
{"title":"[Rare diseases in Iceland].","authors":"Olof Jona Eliasdottir","doi":"10.17992/lbl.2024.03.783","DOIUrl":"10.17992/lbl.2024.03.783","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Laeknabladid
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1